GlassScriptPhysician profile
Tamara Yvette Smith
NPI 1841853223
$3,295.19
in general payments reported to CMS, 2019-2025
23 companies · $739 in 2025
The $739 reported for 2025 was more than what 83% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $603 · 2023: $954 · 2024: $999 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,691.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $928.45 | 2023-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $536.54 | 2022-2024 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $425.07 | 2022-2024 | Farxiga |
| Paratek Pharmaceuticals, INC. | $197.15 | 2023-2024 | Nuzyra |
| Merck Sharp & Dohme LLC | $180.44 | 2022-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $130.79 | 2022-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $124.74 | 2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $121.76 | 2022-2024 | |
| Impulse Dynamics (USA) INC. | $107.72 | 2023 | Optimizer |
| Novo Nordisk INC | $88.55 | 2024-2025 | Wegovy |
| Pfizer INC. | $80.08 | 2023-2025 | |
| Amgen INC. | $63.06 | 2024-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.26 | 2023-2024 | Jardiance |
| Scpharmaceuticals INC. | $48.46 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $33.85 | 2023 | Inpefa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $31.34 | 2022 | |
| Medtronic, INC. | $28.27 | 2022 | |
| Angiodynamics, INC. | $23.16 | 2025 | Auryon Laser System 100-120 Vac |
| Davol INC. | $22.80 | 2025 | Arista |
| Boston Scientific Corporation | $21.18 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $16.64 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $15.59 | 2024 | Nexletol |
| Biotronik INC. | $14.29 | 2023 | Biomonitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.